Literature DB >> 6185570

Regulation of the cytotoxic T lymphocyte response against Sendai virus analyzed with H-2 mutants.

L P de Waal, W M Kast, R W Melvold, C J Melief.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6185570

Source DB:  PubMed          Journal:  J Immunol        ISSN： 0022-1767            Impact factor:   5.422


× No keyword cloud information.
  21 in total

1.  Biochemical analysis of related, independently arising histocompatibility mutants: bm17 and KB-98 enlarge the "bg series" of H-2Kb mutants.

Authors:  G M Pfaffenbach; R W Melvold; S G Nathenson
Journal:  Biochem Genet       Date:  1990-08       Impact factor: 1.890

2.  Protection against lethal Sendai virus infection by in vivo priming of virus-specific cytotoxic T lymphocytes with a free synthetic peptide.

Authors:  W M Kast; L Roux; J Curren; H J Blom; A C Voordouw; R H Meloen; D Kolakofsky; C J Melief
Journal:  Proc Natl Acad Sci U S A       Date:  1991-03-15       Impact factor: 11.205

3.  Analysis of associative recognition determinants on class I H-2Kb mutant molecules.

Authors:  S S Clark; S Geier; S G Nathenson; J Forman
Journal:  Immunogenetics       Date:  1985       Impact factor: 2.846

4.  Structural analysis of an HLA-B27 functional variant: identification of residues that contribute to the specificity of recognition by cytolytic T lymphocytes.

Authors:  M A Vega; A Ezquerra; S Rojo; P Aparicio; R Bragado; J A López de Castro
Journal:  Proc Natl Acad Sci U S A       Date:  1985-11       Impact factor: 11.205

5.  Alternative splicing in the mouse H-2Kd gene is not necessary for the classical Kd antigen function.

Authors:  M Cochet; W M Kast; A M Kummer; C Transy; C J Melief; P Kourilsky
Journal:  Immunogenetics       Date:  1986       Impact factor: 2.846

6.  Differential activation of mouse hepatitis virus-specific CD4+ cytotoxic T cells is defined by peptide length.

Authors:  M H Heemskerk; H M Schoemaker; I De Jong; V E Schijns; W J Spaan; C J Boog
Journal:  Immunology       Date:  1995-08       Impact factor: 7.397

7.  Possible mechanisms by which the H-2Kbm3 mutation may decrease cytotoxic T-lymphocyte recognition of vesicular stomatitis virus nucleoprotein antigen.

Authors:  M R Bowman; D S Lyles; J W Parce
Journal:  J Virol       Date:  1987-06       Impact factor: 5.103

8.  Characterization of the cytolytic T-lymphocyte response to a candidate vaccine strain of equine herpesvirus 1 in CBA mice.

Authors:  P M Smith; Y Zhang; S R Jennings; D J O'Callaghan
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

9.  Human PIV-2 recombinant Sendai virus (rSeV) elicits durable immunity and combines with two additional rSeVs to protect against hPIV-1, hPIV-2, hPIV-3, and RSV.

Authors:  Bart Jones; Xiaoyan Zhan; Vasiliy Mishin; Karen S Slobod; Sherri Surman; Charles J Russell; Allen Portner; Julia L Hurwitz
Journal:  Vaccine       Date:  2009-02-04       Impact factor: 3.641

10.  Crystal structure of the major histocompatibility complex class I H-2Kb molecule containing a single viral peptide: implications for peptide binding and T-cell receptor recognition.

Authors:  W Zhang; A C Young; M Imarai; S G Nathenson; J C Sacchettini
Journal:  Proc Natl Acad Sci U S A       Date:  1992-09-01       Impact factor: 11.205
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.